tirzepatide help with depression New weight-loss drugs linked to lower risk of depression: study

A recent post hoc analysis published in Obesity found tirzepatide vs. placebo was not associated with increased risk of depression symptoms. Rates of suicidal ideation and behavior were low and similar to

21.59

★★★★☆4.8 (126)

Can Tirzepatide (a dual GIP and GLP-1 receptor agonist) cause mood swings in patients with type 2 diabetes, particularly those with a history of depression or anxiety?

27.77

★★★★★4.9 (98)

Obesity is associated with an increased risk of depression and other psychiatric disorders. We (healthcare professionals) monitor in patients prescribed medications approved for weight management. In the SURMOUNT clinical trial program, robust #

22.05

★★★★★5.0 (157)

Once-weekly subcutaneous tirzepatide was not associated with an increased risk of depression compared with placebo, according to a post hoc analysis of the SURMOUNT clinical trial programme. The findings were published in

29.46

★★★★★4.7 (84)

Tirzepatide Weight-Loss Therapy Not Linked to Depression or Suicidal Risk: Study Finds

24.28

★★★★★4.9 (203)

Mounjaro and Depression: Can Tirzepatide Affect Your Mental Health?

26.40

★★★★★5.0 (176)

Can Mounjaro Cause Anxiety and Depression

24.54

★★★★★4.8 (132)